Vibriocidal Antibody Responses to a Bivalent Killed Whole-Cell Oral Cholera Vaccine in a Phase III Trial in Kolkata, India-Reference-Cited by-同舟云学术

Vibriocidal Antibody Responses to a Bivalent Killed Whole-Cell Oral Cholera Vaccine in a Phase III Trial in Kolkata, India

Published:2014-05-06 Issue:5 Volume:9 Page:e96499
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kanungo Suman,Lopez Anna Lena,Ali Mohammad,Manna Byomkesh,Kim Deok Ryon,Mahapatra Tanmay,Holmgren Jan,Dhingra Mandeep S.,Weirzba Thomas F.,Nair G. Balakrish,Bhattacharya Sujit K.,Clemens John D.,Sur Dipika

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference21 articles.

1. Global Alert and Response (GAR): Cholera. WHO.

2. Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam;VD Thiem;Vaccine,2006

3. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam;D Trach;Lancet,1997

4. (2004) WHO Expert Committee on Biological Standardization : fifty-second report. Technical report series (World Health Organization), 924..

5. Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults;DD Anh;Vaccine,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholera Vaccines;Plotkin's Vaccines;2023

2. Immunogenicity and waning immunity from the oral cholera vaccine (Shanchol™) in adults residing in Lukanga Swamps of Zambia;PLOS ONE;2022-01-05

3. A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh;Vaccine;2022-01

4. Immunomodulatory effects of mesenchymal stem cell-conditioned media on lipopolysaccharide of Vibrio cholerae as a vaccine candidate;Stem Cell Research & Therapy;2021-11-03

5. Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139;mSphere;2021-08-25